Fidelity Disruptive Medicine ETF (FMED) is an ETF managed by Fidelity. Its largest position is FIDELITY REVERE STREET TRUST (null), representing 12.56% of fund assets.
Fidelity Disruptive Medicine ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- FMED
- Type:
- ETF
- Manager:
- Fidelity
- Total Assets:
- —
- Report Date:
- Feb 28, 2026
- Filing Date:
- Apr 24, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
FIDELITY REVERE STREET TRUST
|
12.56% | $7,652,468.32 | 7,651,703 |
|
-
DANAHER CORP /DE/
|
4.24% | $2,586,659.20 | 12,280 |
|
-
APPLIED MATERIALS INC /DE
|
4.06% | $2,474,078.62 | 8,299 |
|
-
BOSTON SCIENTIFIC CORP
|
4.04% | $2,459,200.00 | 32,000 |
|
-
ARGENX SE
|
3.84% | $2,341,406.76 | 3,053 |
|
-
Cogent Biosciences, Inc.
|
3.83% | $2,331,000.00 | 60,000 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
3.31% | $2,017,495.20 | 6,060 |
|
-
INTUITIVE SURGICAL INC
|
3.14% | $1,913,338.00 | 3,800 |
|
-
VEEVA SYSTEMS INC
|
2.99% | $1,820,100.00 | 10,000 |
|
-
INSULET CORP
|
2.58% | $1,571,398.92 | 6,372 |
|
-
Moderna, Inc.
|
2.57% | $1,567,404.63 | 29,259 |
|
-
Waystar Holding Corp.
|
2.53% | $1,539,000.00 | 60,000 |
|
-
Edwards Lifesciences Corp
|
2.47% | $1,506,393.87 | 17,421 |
|
-
LifeStance Health Group, Inc.
|
2.46% | $1,497,174.08 | 206,792 |
|
-
Vaxcyte, Inc.
|
2.28% | $1,389,952.62 | 22,513 |
|
-
INSMED Inc
|
1.96% | $1,194,640.00 | 8,000 |
|
-
APPLIED MATERIALS INC /DE
|
1.96% | $1,192,742.84 | 5,513 |
|
-
STRYKER CORP
|
1.86% | $1,133,320.50 | 2,925 |
|
-
ELI LILLY & Co
|
1.78% | $1,083,549.70 | 1,030 |
|
-
Privia Health Group, Inc.
|
1.75% | $1,068,750.00 | 45,000 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
1.74% | $1,060,979.96 | 2,036 |
|
-
Legend Biotech Corp
|
1.73% | $1,052,600.00 | 55,400 |
|
-
10x Genomics, Inc.
|
1.70% | $1,037,250.00 | 45,000 |
|
-
Penumbra Inc
|
1.70% | $1,033,170.00 | 3,000 |
|
-
Kymera Therapeutics, Inc.
|
1.50% | $913,500.00 | 10,000 |
|
-
Stoke Therapeutics, Inc.
|
1.50% | $913,126.39 | 25,079 |
|
-
Ascendis Pharma A/S
|
1.48% | $902,477.50 | 3,865 |
|
-
UNITEDHEALTH GROUP INC
|
1.43% | $871,891.71 | 2,973 |
|
-
Natera, Inc.
|
1.43% | $869,399.16 | 4,179 |
|
-
APPLIED MATERIALS INC /DE
|
1.42% | $866,177.28 | 1,242 |
|
-
CYTOKINETICS INC
|
1.35% | $822,735.06 | 13,223 |
|
-
Caris Life Sciences, Inc.
|
1.32% | $805,600.00 | 40,000 |
|
-
CRINETICS PHARMACEUTICALS INC
|
1.28% | $780,900.00 | 19,000 |
|
-
DEXCOM INC
|
1.26% | $767,270.07 | 10,449 |
|
-
Disc Medicine, Inc.
|
1.21% | $738,016.36 | 11,078 |
|
-
VERACYTE, INC.
|
1.20% | $731,800.00 | 20,000 |
|
-
RESMED INC
|
1.18% | $717,528.00 | 2,800 |
|
-
Xenon Pharmaceuticals Inc.
|
1.11% | $676,895.34 | 15,658 |
|
-
CENTESSA PHARMACEUTICALS PLC
|
1.00% | $612,408.00 | 22,800 |
|
-
NUVALENT INC-A
|
1.00% | $611,700.00 | 6,000 |
|
-
CytomX Therapeutics, Inc.
|
0.99% | $601,810.53 | 112,069 |
|
-
Alignment Healthcare, Inc.
|
0.95% | $578,406.68 | 30,094 |
|
-
ALIGN TECHNOLOGY INC
|
0.93% | $566,307.90 | 2,979 |
|
-
Guardant Health, Inc.
|
0.92% | $563,400.00 | 6,000 |
|
-
Wave Life Sciences, Inc.
|
0.91% | $557,200.00 | 40,000 |
|
-
Kiniksa Pharmaceuticals International, plc
|
0.88% | $533,880.00 | 12,000 |
|
-
Roivant Sciences Ltd.
|
0.85% | $520,920.00 | 18,000 |
|
-
REPLIGEN CORP
|
0.84% | $511,058.10 | 3,970 |
|
-
Enliven Therapeutics, Inc.
|
0.83% | $508,381.87 | 17,123 |
|
-
BIO-TECHNE Corp
|
0.81% | $493,181.00 | 8,359 |
Advertisement (320x50)